Michele Solis | science writer

Menu

Skip to content
  • Selected work
  • Articles
  • About

Picking PIK3CD for schizophrenia treatment

July 30, 2012September 6, 2012michelesolis

A new study plunges into the detailed workings of cells from people with schizophrenia, and emerges with an enzyme called PIK3CD as a potential therapeutic target.

Read this story at Schizophrenia Research Forum.

Related

Schizophrenia Research Forum

Post navigation

← Family roots for mental illness
No medium rare for schizophrenia genetics? →

Publications

  • Distillations
  • IEEE Pulse
  • MSN Health and Fitness
  • Nature
  • Nautilus
  • Pain Research Forum
  • Pharmaceutical Journal
  • Schizophrenia Research Forum
  • Scientific American
  • Scientific American Mind
  • SFARI
  • The Economist
  • the rest–
    • Autism Speaks
    • Crosscut
    • HHMI Bulletin
    • The Scientist
Blog at WordPress.com.